Spindle cell rhabdomyosarcoma: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 06:13, 11 February 2025
Spindle cell rhabdomyosarcoma is a rare subtype of rhabdomyosarcoma, a type of cancer that develops from skeletal muscle cells. It is characterized by elongated, spindle-shaped cells, and is most commonly found in the head and neck, genitourinary tract, and retroperitoneum.
Epidemiology
Spindle cell rhabdomyosarcoma is a rare form of cancer, accounting for less than 3% of all rhabdomyosarcomas. It is most commonly diagnosed in children and young adults, but can occur at any age.
Pathology
The tumor is composed of elongated, spindle-shaped cells that resemble fibroblasts. These cells are arranged in a pattern that resembles a herringbone or fascicular pattern. The cells often express desmin, a protein that is typically found in muscle cells.
Diagnosis
The diagnosis of spindle cell rhabdomyosarcoma is typically made through a combination of imaging studies, biopsy, and histopathological examination. Immunohistochemistry is often used to confirm the diagnosis, with the tumor cells typically expressing desmin and other muscle-specific proteins.
Treatment
The treatment of spindle cell rhabdomyosarcoma typically involves a combination of surgery, radiation therapy, and chemotherapy. The specific treatment plan is determined based on the size and location of the tumor, the patient's overall health, and other factors.
Prognosis
The prognosis for patients with spindle cell rhabdomyosarcoma is generally poor, with a 5-year survival rate of less than 50%. However, the prognosis can vary widely depending on the size and location of the tumor, the patient's overall health, and other factors.


